PPD, Inc. earned numerous honors at the 2021 PharmaTimes Clinical Researcher of the Year-The Americas competition. Two PPD teams won gold, one team won silver and another team took home bronze. PPD clinical researchers also won silver and bronze awards in various individual categories.
Last month, PPD was named “Clinical Research Company of the Year” at the 2021 PharmaTimes Clinical Researcher of the Year International competition in London. In addition to PPD winning the highest honor, a number of individual PPD clinical researchers also took home top honors in the individual categories during the international competition.
“This award demonstrates that PPD’s clinical research experts are among the very best in the field,” said Amber Lee, senior vice president of clinical operations for PPD. “We are proud of our team members’ success in this challenging competition, where they have the ability to exhibit their professional skills in a very competitive environment, reflecting the outstanding work they deliver day-in and day-out for our pharmaceutical and biotech customers.”
The recognition demonstrates the high caliber of PPD’s clinical research professionals and the effectiveness of PPD’s award-winning training and development programs, such as the company’s Clinical Foundations Program and its CRA Academy. These programs help to prepare and equip research professionals to deliver strong performance, quality and value to PPD customers.
The awards are the culmination of a rigorous series of assessments, including a three-stage competition concluding with presentations before a panel of experienced industry judges.
